Preparation of naringenin/ β-cyclodextrin complex and its more potent alleviative effect on choroidal neovascularization in rats.

Preparation of naringenin/ β-cyclodextrin complex and its more potent alleviative effect on choroidal neovascularization in rats.
复制标题

DOI:
10.1155/2014/623509
复制
发表时间:
2014
影响因子:
--
通讯作者:
Yang XW
Yang XW
中科院分区:
生物学3区
文献类型:
--
作者:
Xu XR;Yu HT;Hang L;Shao Y;Ding SH;Yang XW

文献摘要

参考文献

被引文献

相似文献

Choroidal neovascularization (CNV) is characterized by abnormal blood vessels growing from the choroid. Current remedies for CNV have not shown favorable therapeutic efficacy. It is urgent to identify and develop more safe and potent anti-CNV agents via multiple technologies. We previously showed that the natural product naringenin attenuated CNV. However, naringenin has poor water solubility and low bioavailability. Here, we prepared the β-cyclodextrin (β-CD) complex of naringenin and characterized it using infrared spectra and X-ray diffraction analyses. Determination of content and solubility in the complex showed that naringenin accounted for 20.53% in the complex and its solubility was increased by more than 10-fold. Using a laser-induced CNV model in rats we demonstrated that naringenin/β-CD complex more significantly reduced CNV area than naringenin alone in rats. Furthermore, naringenin and its β-CD complex significantly inhibited the mRNA and protein expression of VEGF, COX-2, PI3K, p38MAPK, MMP-2, and MMP-9 in retina and choroid tissues. Naringenin/β-CD complex showed more significant inhibitory effect on VEGF and COX-2 expression than naringenin. These results collectively indicated that naringenin/β-CD complex could be a promising therapeutic option for CNV and that the beneficial effects could be linked to the anti-inflammatory properties of naringenin.
DOI: 10.1038/gt.2008.185
发表时间: 2009-05
期刊: Gene therapy
影响因子: 5.1
作者:
通讯作者: --
DOI: 10.1016/j.ophtha.2005.02.007
发表时间: 2005-06-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Michels, S;Rosenfeld, PJ;Venkatraman, AS
通讯作者: Venkatraman, AS
DOI: 10.1096/fj.03-0473com
发表时间: 2004-02-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Kuwano, T;Nakao, S;Ono, M
通讯作者: Ono, M
DOI: 10.1371/journal.pone.0018033
发表时间: 2011-04-06
期刊: PloS one
影响因子: 3.7
作者:
Shulman M;Cohen M;Soto-Gutierrez A;Yagi H;Wang H;Goldwasser J;Lee-Parsons CW;Benny-Ratsaby O;Yarmush ML;Nahmias Y
通讯作者: Nahmias Y
DOI: 10.1186/1471-2407-6-181
发表时间: 2006-07-10
期刊: BMC cancer
影响因子: 3.8
作者:
Larkins TL;Nowell M;Singh S;Sanford GL
通讯作者: Sanford GL